The difference between a promising therapy and a transformative one often comes down to delivery. Continuity Biosciences builds precision delivery platforms that close the gap between what a therapy can do and what a patient actually experiences. Our adaptive, therapy-agnostic technologies support applications across oncology, chronic disease, and medical aesthetics, spanning small molecules, biologics, and cell-based therapies. We don't build around a single drug or indication. We build infrastructure for better therapeutic delivery, wherever it matters most. Our science is rooted in research from Houston Methodist, University of Miami, University of North Carolina. Our collective work spans 135 publications and 80 patents—not as a measure of the past, but as a foundation for what comes next. We welcome conversations with partners, investors, and collaborators. Reach out or follow along as we build.
We're tracking Continuity Biosciences, LLC's market expansion
How Continuity Biosciences, LLC's international expansion compares to its competitors
Continuity Biosciences, LLCYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Continuity Biosciences, LLCYou | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Continuity Biosciences launched Phase I trial for pancreatic cancer using iontophoretic platform to deliver gemcitabine directly to tumors, enrolling at WVU and University of Michigan medical centers.
Continuity Biosciences initiated Phase 1 trial evaluating gemcitabine via IOP platform for pancreatic cancer at major academic centers including WVU Medicine and University of Michigan.
Continuity Biosciences initiates first-in-human Phase 1 clinical trial evaluating gemcitabine delivery via its iontophoretic oncology platform for pancreatic cancer treatment at leading academic medical centers.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Continuity Biosciences, LLC's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
